[MUV Researcher of the Month, March 2015]

Overview

Journal Wien Klin Wochenschr

Publisher Springer

Specialty General Medicine

Date 2015 Mar 22

PMID 25794564

Authors

Martin Bauer

Affiliations

Soon will be listed here.

References

Bauer M, Karch R, Neumann F, Abrahim A, Wagner C, Kletter K . Age dependency of cerebral P-gp function measured with (R)-[11C]verapamil and PET. Eur J Clin Pharmacol. 2009; 65(9):941-6. PMC: 3689922. DOI: 10.1007/s00228-009-0709-5. View

Feldmann M, Asselin M, Liu J, Wang S, McMahon A, Anton-Rodriguez J . P-glycoprotein expression and function in patients with temporal lobe epilepsy: a case-control study. Lancet Neurol. 2013; 12(8):777-85. DOI: 10.1016/S1474-4422(13)70109-1. View

Langer O, Bauer M, Hammers A, Karch R, Pataraia E, Koepp M . Pharmacoresistance in epilepsy: a pilot PET study with the P-glycoprotein substrate R-[(11)C]verapamil. Epilepsia. 2007; 48(9):1774-1784. DOI: 10.1111/j.1528-1167.2007.01116.x. View

Bauer M, Karch R, Zeitlinger M, Stanek J, Philippe C, Wadsak W . Interaction of 11C-tariquidar and 11C-elacridar with P-glycoprotein and breast cancer resistance protein at the human blood-brain barrier. J Nucl Med. 2013; 54(8):1181-7. PMC: 3882137. DOI: 10.2967/jnumed.112.118232. View

Bauer M, Zeitlinger M, Karch R, Matzneller P, Stanek J, Jager W . Pgp-mediated interaction between (R)-[11C]verapamil and tariquidar at the human blood-brain barrier: a comparison with rat data. Clin Pharmacol Ther. 2011; 91(2):227-33. PMC: 3685270. DOI: 10.1038/clpt.2011.217. View

van Assema D, Lubberink M, Bauer M, van der Flier W, Schuit R, Windhorst A . Blood-brain barrier P-glycoprotein function in Alzheimer's disease. Brain. 2011; 135(Pt 1):181-9. DOI: 10.1093/brain/awr298. View

Bauer M, Karch R, Zeitlinger M, Liu J, Koepp M, Asselin M . In vivo P-glycoprotein function before and after epilepsy surgery. Neurology. 2014; 83(15):1326-31. PMC: 4189097. DOI: 10.1212/WNL.0000000000000858. View

Wagner C, Bauer M, Karch R, Feurstein T, Kopp S, Chiba P . A pilot study to assess the efficacy of tariquidar to inhibit P-glycoprotein at the human blood-brain barrier with (R)-11C-verapamil and PET. J Nucl Med. 2009; 50(12):1954-61. PMC: 3690436. DOI: 10.2967/jnumed.109.063289. View

Bauer M, Karch R, Neumann F, Wagner C, Kletter K, Muller M . Assessment of regional differences in tariquidar-induced P-glycoprotein modulation at the human blood-brain barrier. J Cereb Blood Flow Metab. 2009; 30(3):510-5. PMC: 2949150. DOI: 10.1038/jcbfm.2009.265. View

10.

Bauer M, Langer O, Dal-Bianco P, Karch R, Brunner M, Abrahim A . A positron emission tomography microdosing study with a potential antiamyloid drug in healthy volunteers and patients with Alzheimer's disease. Clin Pharmacol Ther. 2006; 80(3):216-27. DOI: 10.1016/j.clpt.2006.05.007. View